Form 4 for IPSC Century Therapeutics, Inc.
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-16 · accession 0001062993-24-003878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-21 | 2024-02-16 | IPSC | Farid Adrienne | Chief Ops Off | S - Sale+OE | $4.86 | -485 | 114.1K | -0.4% | -$2,357 |
| D | 2024-02-21 | 2024-02-16 | IPSC | Farid Adrienne | Chief Ops Off | M - OptEx | $1.03 | +485 | 114.6K | +0.4% | +$499.55 |
| D | 2024-02-21 | 2024-02-16 | IPSC | Farid Adrienne | Chief Ops Off | M - OptEx | $0.00 | -485 | 222.2K | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-16 | S | D | 485 | $4.86 | 114,149 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.85 to $4.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-02-16 | M | A | 485 | $1.03 | 114,634 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-02-16 | M | D | 485 | $0.00 | 222,170 | D | $1.03 · — to 2029-07-17 | 485 Common Stock | (F3) The option is fully vested and exercisable. |